Cargando…

Modeling rapid and selective capture of nNOS–PSD-95 uncouplers from Sanhuang Xiexin decoction by novel molecularly imprinted polymers based on metal–organic frameworks

Novel and highly selective molecularly imprinted polymers based on the surface of metal–organic frameworks, NH(2)-MIL-101(Cr) (MIL@MIP(S)), were successfully fabricated to capture neuronal nitric oxide synthase–postsynaptic density protein-95 (nNOS–PSD-95) uncouplers from Sanhuang Xiexin Decoction (...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Linli, Ding, Yingying, Ni, Xiaoting, Wang, Chong-Zhi, Jiang, Bo, Zhang, Yu, Jiang, Nan, Tang, Yulin, Chen, Lina, Yuan, Chun-Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049783/
https://www.ncbi.nlm.nih.gov/pubmed/35492204
http://dx.doi.org/10.1039/c9ra10537a
Descripción
Sumario:Novel and highly selective molecularly imprinted polymers based on the surface of metal–organic frameworks, NH(2)-MIL-101(Cr) (MIL@MIP(S)), were successfully fabricated to capture neuronal nitric oxide synthase–postsynaptic density protein-95 (nNOS–PSD-95) uncouplers from Sanhuang Xiexin Decoction (SXD) for stroke treatment. The resultant polymers were characterized by Fourier transform infrared spectroscopy, scanning electron microscopy, thermogravimetric analysis, and X-ray diffraction. The performance tests revealed that MIL@MIPs had a large binding capacity, fast kinetics, and excellent selectivity. Then the obtained polymers were satisfactorily applied to solid-phase extraction coupled with high-performance liquid chromatography to selectively capture nNOS–PSD-95 uncouplers from SXD. Furthermore, the biological activities of components obtained from SXD were evaluated in vivo and in vitro. As a consequence, the components showed a potent neuroprotective effect from the MTS assay and uncoupling activity from the co-immunoprecipitation experiment. In addition, the anti-ischemic stroke assay in vivo was further investigated to determine the effect of reducing infarct size and ameliorating neurological deficit by the active components. Therefore, this present study contributes a valuable new method and new tendency to selectively capture active components for stroke treatment from SXD and other natural medicines.